AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15104559
Drug: rhGH replacement
RxNorm normalized name: rhGH
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhGH replacement therapy + alendronate (10 mg/day) for 3 years
Trial: 15104559
Drug: alendronate treatment
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: alendronate treatment
Trial: 9764990
Drug: Norfloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin (400 mg/day for 6 months)
Trial: 7836511
Drug: Naproxen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (500 mg every 12 hours for five doses starting 4 days after LH surge)
Trial: 2899719
Drug: Recombinant alpha
RxNorm normalized name: Recombinant alpha glucosidase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant alpha 2‐interferon at doses of 2.5, 5, or 10 X 10(6) U/m2 intramuscularly thrice weekly for 12‐24 weeks
Trial: 31784746
Drug: Circulating triglycerides
RxNorm normalized name: CAPRYLIC TRIGLYCERIDE
DrugBank: Tricaprylin (DB12176)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Circulating triglycerides (TG) measured via log transformation of mg/dl data
Trial: 26901007
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g I/kg BW
Trial: 26901007
Drug: 0.4 g
RxNorm normalized name: psyllium 0.4 GM Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 g I/kg BW
Trial: 26901007
Drug: 0.3 g
RxNorm normalized name: sorbitol 0.3 GM Oral Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g I/kg BW
Trial: 17161535
Drug: Lamotrigine 400
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine 400 mg
Trial: 17161535
Drug: Lamotrigine 200
RxNorm normalized name: lamotrigine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine 200 mg
Trial: 17161535
Drug: Lamotrigine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (300 and 400 mg)
Trial: 10445538
Drug: Oral magnesium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral magnesium citrate (296 cc) with oral bisacodyl (10 mg)
Trial: 10445538
Drug: Oral magnesium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral magnesium citrate (296 cc) with one hypertonic phosphate enema
Trial: 10445538
Drug: Oral magnesium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral magnesium citrate (296 cc) with two hypertonic phosphate enemas
Trial: 10445538
Drug: Oral bisacodyl
RxNorm normalized name: bisacodyl Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bisacodyl regimen
Trial: 10445538
Drug: Oral bisacodyl
RxNorm normalized name: bisacodyl Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bisacodyl preparation
Trial: 7847429
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone injections (0.05 mg/kg IBW for 28 days)
Trial: 387417
Drug: Pirbuterol 10
RxNorm normalized name: pirbuterol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirbuterol 10 mg plus hydroxyzine 10 mg
Trial: 387417
Drug: Pirbuterol 10
RxNorm normalized name: pirbuterol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirbuterol 10 mg plus placebo
Trial: 14693576
Drug: 250 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg/kg FDP IV before surgery and 2.5 mM FDP as a cardioplegic additive (n = 15)
Trial: 14693576
Drug: FDP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDP treatment across all regimens (n = 88; 44 FDP, 44 control)
Trial: 11836046
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 625 mg (250 mg elemental calcium) three times a day (group A)
Trial: 11836046
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 625 mg (250 mg elemental calcium) plus 0.625 mg/day of conjugated equine estrogen and 5 mg medrogestone acetate (group B)
Trial: 10071455
Drug: Control (flomoxef
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (flomoxef sodium and tobramycin without G-CSF)
Trial: 2247106
Drug: A‐64077 (5‐lipoxygenase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A‐64077 (5‐lipoxygenase inhibitor)
Trial: 25770987
Drug: Heparin-bonded grafts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-bonded grafts
Trial: 17047639
Drug: Hypertriglyceridemic waist
RxNorm normalized name: histamine
DrugBank: Histamine (DB05381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypertriglyceridemic waist (HTGW) defined as waist circumference (WC) > or =90 cm and triglycerides (TG) > or =2 mmol/l
Trial: 7779548
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (100 micrograms daily as enriched yeast for 4 months)
Trial: 2157450
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (30 g/day)
Trial: 393519
Drug: Flutonidin (0.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutonidin (0.5, 1, 2 mg)
Trial: 393519
Drug: Clonidine (0.0075,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.0075, 0.150, 0.300 mg)
Trial: 30217337
Drug: Re-irradiation with
RxNorm normalized name: Re-Covr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Re-irradiation with stereotactic body radiation therapy (SBRT), median BED10 of first SBRT 59.5 Gy (48-85.5 Gy), second SBRT 50.2 Gy (43.7-66.9 Gy) in training cohort; median BED10 of first SBRT 59.5 Gy (52.5-66.9 Gy), second SBRT 47.7 Gy (40.6-54.8 Gy) in validation cohort.
Trial: 23147173
Drug: Atorvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (80 mg within 24 hours before contrast media exposure)
Trial: 20030684
Drug: Early steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early steroid withdrawal (at day 5)
Trial: 20030684
Drug: Late steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late steroid withdrawal (at month 6)
Trial: 18928685
Drug: Nebulised single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised single dose of two 12 microg Formoterol Fumarate capsules diluted in 2.5 ml of sterile saline solution.
Trial: 18928685
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of Albuterol (0.15 mg/kg/dose, maximum dose 2.5 mg) every twenty minutes for one hour.
Trial: 11796358
Drug: Valaciclovir with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir with 1 g of probenecid
Trial: 11796358
Drug: Valaciclovir with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir with 800 mg of cimetidine
Trial: 10374166
Drug: Topical diclofenac
RxNorm normalized name: diclofenac Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diclofenac eyedrops
Trial: 10374166
Drug: Topical prednisolone
RxNorm normalized name: prednisolone Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical prednisolone acetate eyedrops
Trial: 1880232
Drug: Test drug
RxNorm normalized name: URINE TEST DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test drug (specific NSAIDs and centrally acting analgesic) administered 30 minutes before RSE.
Trial: 1880232
Drug: Standard drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard drugs (NSAIDs and centrally acting analgesic).
Trial: 6313591
Drug: Acyclovir (ACV)
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir (ACV) administered intravenously at 8-hourly intervals, total daily dosage of 1500 mg/m2 for 5 days.
Trial: 25280408
Drug: Hypoxia with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoxia with 8% maltodextrin (200 mL/20 min) during exercise and for 2 h after
Trial: 25280408
Drug: Hypoxia after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoxia after 6 d of glutamine supplementation (20 g/d) and supplementation with 8% maltodextrin (200 mL/20 min) during exercise and for 2 h after
Trial: 22320409
Drug: midazolam+fentanyl and
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: midazolam+fentanyl and topical anesthesia
Trial: 22320409
Drug: dexmedetomidine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexmedetomidine and topical anesthesia
Trial: 20034685
Drug: Metformin 850
RxNorm normalized name: metFORMIN 850 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 850 mg/d
Trial: 21194594
Drug: Metformin 850
RxNorm normalized name: metFORMIN 850 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 850 mg/d + Atorvastatin 10 mg/d
Trial: 7582165
Drug: Parenteral paramethasone
RxNorm normalized name: paramethasone
DrugBank: Paramethasone acetate (DB14657)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Parenteral paramethasone (Triniol)
Trial: 7582165
Drug: Other corticosteroids
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other corticosteroids (oral and parenteral challenges)
Trial: 1541981
Drug: rIL‐2 alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rIL‐2 alone (10,000 IU/injection, escalated to 50,000 IU)
Trial: 31651801
Drug: IV ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV ibuprofen (10 mg/kg, max 800 mg)
Trial: 26137537
Drug: Oral artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral artesunate (200 mg, 14 daily doses)
Trial: 21204958
Drug: Nateglinide 120
RxNorm normalized name: nateglinide 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nateglinide 120 mg three times daily prior to meals
Trial: 21204958
Drug: Glyburide 5
RxNorm normalized name: glyburide 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide 5 mg once daily before breakfast
Trial: 18078907
Drug: Calcium acetate
RxNorm normalized name: Calcium Acetate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium acetate plus atorvastatin (Lipitor)
Trial: 16492394
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (iNO) at concentrations of 5, 10, 20, and 40 parts per million (ppm) for 15 min
Trial: 7942731
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg/day for 8 days
Trial: 7942731
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg/day for 8 days
Trial: 3220075
Drug: Glucose polymer
RxNorm normalized name: glucose polymers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose polymer (GP) diet supplement (230 g of GP consumed daily)
Trial: 3220075
Drug: Glucose polymer
RxNorm normalized name: glucose polymers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose polymer (GP) diet supplement
Trial: 3220075
Drug: Placebo (saccharin‐sweetened
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saccharin‐sweetened supplement)
Trial: 27926471
Drug: External beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External beam radiation therapy (EBRT) ≥40 Gy
Trial: 27926471
Drug: Any kind
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any kind of chemotherapy (CTX)
Trial: 27926471
Drug: Multimodal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal treatment regimen
Trial: 25469044
Drug: Boceprevir-based triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Boceprevir-based triple therapy (PEG-IFNα2b/RBV followed by PEG-IFNα2b/RBV+Boceprevir for 32 weeks)
Trial: 25469044
Drug: Boceprevir-based triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Boceprevir-based triple therapy
Trial: 23122795
Drug: Chronic subcutaneous
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic subcutaneous B-type natriuretic peptide (BNP) 10 μg/kg bid for 8 weeks
Trial: 19644406
Drug: 100 mg.d(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg.d(‐1) CoQ10
Trial: 18599165
Drug: IC51 vaccine
RxNorm normalized name: Japanese encephalitis vaccine IC51
DrugBank: Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IC51 vaccine
Trial: 18599165
Drug: JE-VAX vaccine
RxNorm normalized name: Je-Vax Vaccine Powder for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JE-VAX vaccine
Trial: 7540566
Drug: 50 IU
RxNorm normalized name: Pegaspargase 750 IU/1 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 IU oxytocin diluted in 10 ml 0.9% sodium chloride solution
Trial: 7540566
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml plasma expander (dextran 70) into the umbilical vein
Trial: 2574262
Drug: Intramuscular quinine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular quinine (20 mg salt/kg followed by 10 mg/kg every 12 h)
Trial: 5762041
Drug: (-)-hyoscine 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (-)-hyoscine 0.4 mg
Trial: 5762041
Drug: (-)-hyoscine 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (-)-hyoscine 0.2 mg
Trial: 5762041
Drug: (-)-hyoscine 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (-)-hyoscine 0.1 mg
Trial: 5762041
Drug: (-)-hyoscine 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (-)-hyoscine 0.05 mg
Trial: 28687377
Drug: Whole Brain
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole Brain Radiotherapy (WBRT) - 30 Gy in ten daily fractions or 37.5 Gy in 15 daily fractions
Trial: 26258842
Drug: ABA training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABA training combined with oral bumetanide (0.5 mg twice a day)
Trial: 20842417
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine and Western medicine (TCM)
Trial: 20842417
Drug: Conventional Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Western medicine treatment (WM)
Trial: 17920550
Drug: Statins in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statins in combination with existing agents for multiple sclerosis therapy
Trial: 11457465
Drug: HN-11 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HN-11 500 (1, 10, 100, 200, and 400 mg)
Trial: 11457465
Drug: HN-11 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HN-11 500 (400 mg)
Trial: 11457465
Drug: HN-11 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HN-11 500 (10 mg)
Trial: 349324
Drug: Hexoprenaline sulphate
RxNorm normalized name: hexoprenaline
DrugBank: Hexoprenaline (DB08957)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexoprenaline sulphate (1 mg)
Trial: 25275341
Drug: Enzyme combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzyme combination (XB)
Trial: 25275341
Drug: Essential oils
RxNorm normalized name: essential oils
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential oils + enzyme combination (EO+XB)
Trial: 22729296
Drug: Maltodextrin at
RxNorm normalized name: Maltodextrin
DrugBank: Maltodextrin (DB12583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maltodextrin at 12.5% (400 ml 6 hours before and 200 ml 2 hours before)
Trial: 17978033
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered after precompetition training with morphine
Trial: 17978033
Drug: Morphine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine administered during precompetition training
Trial: 15726333
Drug: Intravenous cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cocaine (0, 8, 16, and 32 mg per 70 kg)
Trial: 15903
Drug: Intraamniotic prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraamniotic prostaglandin F2alpha (50 mg single dose)
Trial: 15903
Drug: Intraamniotic prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraamniotic prostaglandin F2alpha (25 mg repeated dose)
Trial: 19332204
Drug: Transradial PCI
RxNorm normalized name: PCI-27483
DrugBank: PCI-27483 (DB13000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transradial PCI with maximal antiplatelet therapy (aspirin and clopidogrel, 70 U/kg heparin, abciximab before first balloon inflation)
Trial: 16494145
Drug: Patient controlled
RxNorm normalized name: PATIENT CONTROLLED ANALGESIA VIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient controlled intravenous morphine (Group C - control group)
Trial: 8445231
Drug: Oral pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pulse prednisone therapy (90 mg daily for 5 days each month)
Trial: 8445231
Drug: Conventional daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional daily dose therapy with prednisone in combination with azathioprine
Trial: 8445231
Drug: Oral pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pulse prednisone therapy
Trial: 3524066
Drug: Indomethacin, 50
RxNorm normalized name: Indomethacin, 50 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin, 50 mg t.i.d. for 6 days
Trial: 24481415
Drug: Conventional stepwise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional stepwise predefined fever management using antipyretic medication and surface cooling (Control)
Trial: 22751270
Drug: Integrated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated treatment combining medical-nutritional interventions and family psychotherapy
Trial: 11814498
Drug: PGE2 (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGE2 (2.5 mg)
Trial: 7591118
Drug: Norwegian group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norwegian group B meningococcal OMV vaccine (3 doses)
Trial: 7591118
Drug: Norwegian group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norwegian group B meningococcal OMV vaccine (2 doses)
Trial: 2186023
Drug: Clonazepam treatment
RxNorm normalized name: Clonazepam
DrugBank: Clonazepam (DB01068)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonazepam treatment group
Trial: 368045
Drug: Penfluridol (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penfluridol (once weekly)
Trial: 368045
Drug: Chlorpromazine (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (once daily)
Trial: 31814312
Drug: Directly observed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Directly observed therapy (DOT) during the continuation phase of anti-TB therapy
Trial: 31814312
Drug: Body mass
RxNorm normalized name: Total Body Massager Item
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Body mass index (BMI) change during anti-TB treatment
Trial: 28418209
Drug: Acupressure band
RxNorm normalized name: Band-Aid Hurt-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupressure band at the Neiguan point (P6) for 12 hours daily for three days
Trial: 26978418
Drug: ARTRA MSM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARTRA MSM (400 mg chondroitin sulfate, 500 mg glucosamine hydrochloride, 300 mg methylsulfonylmethane (MSM), and 10 mg sodium hyaluronate) taken as 2 tablets daily for one month, then 1 tablet daily
Trial: 1761065
Drug: Verapamil 240
RxNorm normalized name: verapamil 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 240 mg b.d. for 1 week
Trial: 30680768
Drug: Aflibercept monotherapy
RxNorm normalized name: Aflibercept
DrugBank: Aflibercept (DB08885)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aflibercept monotherapy (AM)
Trial: 25683116
Drug: larazotide acetate
RxNorm normalized name: Larazotide
DrugBank: Larazotide (DB05645)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: larazotide acetate 0.5 mg 3 times daily
Trial: 24804871
Drug: Trans-resveratrol (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trans-resveratrol (250 mg) with 20 mg piperine
Trial: 24804871
Drug: Trans-resveratrol (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trans-resveratrol (250 mg)
Trial: 21519222
Drug: Palonosetron +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron + Dexamethasone (8-mg dexamethasone + 0.075-mg palonosetron)
Trial: 21519222
Drug: Palonosetron alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron alone (0.075 mg palonosetron)
Trial: 19242322
Drug: Unfractioned heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unfractioned heparin (UFH) 500 units/hour for 7 days
Trial: 14666114
Drug: L‐759274 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐759274 40 mg daily
Trial: 9696260
Drug: Conventional flap
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional flap therapy